Physician

Omayra Ortiz, M.D.

According to 2025 Medicare claims, Omayra Ortiz, M.D. (NPI: 1124068853) practices general psychiatry in the New York-Jersey City-White Plains, NY-NJ market, with the plurality of this provider's patient population coming from Hudson, NJ. This provider's primary affiliated billing organization is PREMIER PSYCHIATRIC CONSULTANTS LLC (NPI: 1508182072) and primary practice location at 07093-9998. Ortiz is affiliated with the RWJBH Accountable Care, LLC (ACO ID: A1247), participating under the MSSP model.

Ortiz's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 17 traditional Medicare patients, billed 303 HCPCS/CPT codes, and received $21,440 in Medicare payments. The top billing code was 99213 (Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more). Part D data shows 358 prescription claims across 21 beneficiaries totaling $19,844 in drug costs, led by Quetiapine Fumarate (Quetiapine Fumarate). No Open Payments records. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has fallen sharply in recent years, from $10,083 to $21,440. Similarly, Part D prescription costs have fallen sharply in recent years, from $138,201 to $19,844. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$120K$240K2015 Medicare payment: $10,083 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $149,045 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $226,490 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $240,018 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $107,179 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $6,216 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $20,056 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $21,440 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
201577196$10,083
20161972,054$149,045
20172723,507$226,490
20182813,716$240,018
20192051,745$107,179
2020N/RN/RN/R
2021N/RN/RN/R
20221570$6,216
202318271$20,056
202417303$21,440

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$104K$207K2015 Drug cost: $138,201 (USD; Tot_Drug_Cst)2016 Drug cost: $114,165 (USD; Tot_Drug_Cst)2017 Drug cost: $194,330 (USD; Tot_Drug_Cst)2018 Drug cost: $207,038 (USD; Tot_Drug_Cst)2019 Drug cost: $120,463 (USD; Tot_Drug_Cst)2020 Drug cost: $994 (USD; Tot_Drug_Cst)2022 Drug cost: $1,429 (USD; Tot_Drug_Cst)2023 Drug cost: $15,882 (USD; Tot_Drug_Cst)2024 Drug cost: $19,844 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
20151141,210$138,201
20161841,627$114,165
20172473,292$194,330
20182794,564$207,038
20192232,441$120,463
20201445$994
2021N/RN/RN/R
20221143$1,429
202319347$15,882
202421358$19,844

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
99213Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more13103$74
90833Psychotherapy with evaluation and management visit, 30 minutes17148$58

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
Quetiapine FumarateQuetiapine Fumarate371,170$762
OxcarbazepineOxcarbazepine12360$631
Duloxetine HclDuloxetine Hcl13390$514
MirtazapineMirtazapine29852$360
Escitalopram OxalateEscitalopram Oxalate431,350$288

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary

No connected Open Payments records were found for this physician in General Payments, Research Payments, or Ownership / Investment Interests.

FAQ

What Medicare data is available for Omayra Ortiz, M.D.?

Tedicare shows public-source Medicare data for Omayra Ortiz, M.D. (NPI 1124068853), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Omayra Ortiz, M.D. have ACO affiliation data?

Omayra Ortiz, M.D. is shown with ACO affiliation data for RWJBH Accountable Care, LLC (MSSP, ACO ID A1247).

What billing organization is linked to Omayra Ortiz, M.D.?

Omayra Ortiz, M.D. is linked to PREMIER PSYCHIATRIC CONSULTANTS LLC (billing NPI 1508182072) in the available physician profile data.

Does Omayra Ortiz, M.D. have Open Payments data?

No connected Open Payments records are shown for this physician in the available General Payments, Research Payments, or Ownership / Investment Interests data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.